Transcept Pharmaceuticals Appoints Key Senior Executives RICHMOND, Calif., July 2 /PRNewswire/ -- Transcept Pharmaceuticals, Inc.today announced the appointment of Terrence Moore to the position of Vice President, Marketing and Sales and Susan Koppy to the position of Vice President, Corporate...
Transcept Pharmaceuticals Appoints Key Senior Executives RICHMOND, Calif., July 2 /PRNewswire/ -- Transcept Pharmaceuticals, Inc.today announced the appointment of Terrence Moore to the position of Vice President, Marketing and Sales and Susan Koppy to the position of Vice President, Corporate...
Transcept Pharmaceuticals Appoints Key Senior Executives RICHMOND, Calif., July 2 /PRNewswire/ -- Transcept Pharmaceuticals, Inc.today announced the appointment of Terrence Moore to the position of Vice President, Marketing and Sales and Susan Koppy to the position of Vice President, Corporate...
Transcept Pharmaceuticals Appoints Key Senior Executives RICHMOND, Calif., July 2 /PRNewswire/ -- Transcept Pharmaceuticals, Inc.today announced the appointment of Terrence Moore to the position of Vice President, Marketing and Sales and Susan Koppy to the position of Vice President, Corporate...
Transcept Pharmaceuticals Appoints Key Senior Executives RICHMOND, Calif., July 2 /PRNewswire/ -- Transcept Pharmaceuticals, Inc.today announced the appointment of Terrence Moore to the position of Vice President, Marketing and Sales and Susan Koppy to the position of Vice President, Corporate...
Transcept Pharmaceuticals Appoints Key Senior Executives 'I am delighted to join the Transcept management team at such an exciting time in the company's development,' said Mr.Moore.
'Intermezzo(R) has the potential to become an innovative low dose solution for insomnia patients who wake up in...
Is Vitamin Deficiency At The Bottom Of Burning Sensation? The People's Pharmacy with Joe and Terry Graedon www.PeoplesPharmacy.com Newspaper Columns, Pharmacy Q&A June 20, 2008 Q.Can you help me?
Ive had a burning sensation on my tongue and the soles of my feet for weeks?
Ive tried...
Transcept Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference RICHMOND, Calif.The presentation will be available as a webcast at http://www.wsw.com/webcast/jeff26/transcept.
About Transcept Pharmaceuticals Transcept Pharmaceuticals, Inc.
is a specialty pharmaceutical company deriving significant...
Roxane Laboratories, Inc Announces the Launch of Ramipril Capsules 6/19/2008 7:38:16 AM More...Roxane Laboratories, Inc.Announces the Launch of Zaleplon Capsules CIV 6/9/2008 7:45:43 AM More...
Roxane Laboratories, Inc.Announces the Launch of Acarbose Tablets 5...
Transcept Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference RICHMOND, Calif., June 18 /PRNewswire/ -- Transcept Pharmaceuticals, Inc.today announced that Glenn A.
Oclassen, President & Chief Executive Officer, will present at the Jefferies 2nd Annual Healthcare Conference in New York City on...
Transcept Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference RICHMOND, Calif., June 18 /PRNewswire/ -- Transcept Pharmaceuticals, Inc.today announced that Glenn A.
Oclassen, President & Chief Executive Officer, will present at the Jefferies 2nd Annual Healthcare Conference in New York City on...
Transcept Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference RICHMOND, Calif., June 18 /PRNewswire/ -- Transcept Pharmaceuticals, Inc.today announced that Glenn A.
Oclassen, President & Chief Executive Officer, will present at the Jefferies 2nd Annual Healthcare Conference in New York City on...
Transcept Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference The presentation will be available as a webcast at http://www.wsw.com/webcast/jeff26/transcept.About Transcept Pharmaceuticals Transcept Pharmaceuticals, Inc.
is a specialty pharmaceutical company deriving significant new patient...
Transcept Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference RICHMOND, Calif., June 18 CA-Transcept-present PT.RICHMOND, Calif., June 18 /PRNewswire/ -- Transcept Pharmaceuticals, Inc.
today announced that Glenn A.
Oclassen, President & Chief Executive Officer, will present at the Jefferies...
Transcept Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference /PRNewswire/ -- Transcept Pharmaceuticals, Inc.today announced that Glenn A.
Oclassen, President & Chief Executive Officer, will present at the Jefferies 2nd Annual Healthcare Conference in New York City on Wednesday, June 25, 2008...
Transcept Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference RICHMOND, Calif., June 18 /PRNewswire/ -- Transcept Pharmaceuticals, Inc.today announced that Glenn A.
Oclassen, President & Chief Executive Officer, will present at the Jefferies 2nd Annual Healthcare Conference in New York...
Transcept Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference AM PT.RICHMOND, Calif., June 18 /PRNewswire/ -- Transcept Pharmaceuticals, Inc.
today announced that Glenn A.
Oclassen, President & Chief Executive Officer, will present at the Jefferies 2nd Annual Healthcare Conference in New...
Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose Data Presented as Poster Presentation at the Associated Professional Sleep Societies 2008 Annual Meeting BALTIMORE, June 11 /PRNewswire/ -- Data was presented today at the 22nd Annual Meeting of the Associated Professional Sleep Societies ...
Intermezzo 3.5 mg Achieves Greater Early Bioavailability Than Ambien 10 mg Despite 65% Lower Dose Data Presented as Poster Presentation at the Associated Professional Sleep Societies 2008 Annual Meeting BALTIMORE, June 11, 2008 /PRNewswire/ -- Data was presented today at the 22nd Annual Meeting of the Associated Professional Sleep...
Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose Data Presented as Poster Presentation at the Associated Professional Sleep Societies 2008 Annual Meeting BALTIMORE, June 11 /PRNewswire/ -- Data was presented today at the 22nd Annual Meeting of the Associated Professional Sleep Societies ...
Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patie Ambien CR(R) 12.5 mg significantly improved sleep onset, sleep maintenance and total sleep time compared to placebo BRIDGEWATER, N.J., June 10 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today results from a new study that showed...
New Research on Insomnia Sleep Disorders May Precede or Exacerbate Psychiatric Conditions Dr Mendelson was professor of psychiatry and clinical pharmacology at the University of Chicago, where he was also director of the Sleep Research Laboratory.He is now a...
InvestSource Inc.: Global Entertainment Announces Major Deal to Produce 'Screwballs' Sequel (M2 PRESSWIRE via COMTEX) -- PAY | Quote | Chart | News | PowerRating -- Stocks in the News: Entertainment Acquisition Corporation (Other OTC: PSRZ), Precision Drilling Trust (NYSE: PDS), SkyWest, Inc.(NASDAQ: SKYW), General Mills (NYSE:...
Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved BRIDGEWATER, N.J., June 10 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today results from a new study that showed Ambien CR(R) (zolpidem tartrate extended-release) CIV tablets 12.5 mg provided significant improvement in sleep...
Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patie Ambien CR(R) 12.5 mg significantly improved sleep onset, sleep maintenance and total sleep time compared to placebo BRIDGEWATER, N.J., June 10 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today results from a new study that showed...
